Fox Chase Virtua Health Cancer Program

Philadelphia, Pennsylvania 08060

0 studies enrolling now · 1 studies all time

What they study most

Head and Neck, Squamous Cell Cancer

Studies at this site

• Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer — Completed